1. Age: 18-75 years old, no limitation in gender; 
2. Left ventricular ejection fraction (LVEF) â‰¤ 40% (ECHO); 
3. Patients with chronic heart failure (NYHA class II or III); 
4. In the past one month, the clinical condition (including history, clinical symptoms and signs) was relatively stable; 
5. Patients on standard treatment of chronic heart failure at the target dose or maximum tolerance dose for over 1 month ,or unchanged dose in last 1 month; 
6. Understand and sign the informed consent form; 
